Febarbamate
Title: Febarbamate
CAS Registry Number: 13246-02-1
CAS Name: 1-[2-[(Aminocarbonyl)oxy]-3-butoxypropyl]-5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione
Additional Names: 1-(3-butoxy-2-hydroxypropyl)-5-ethyl-5-phenylbarbituric acid carbamate; 1-(3-butoxy-2-carbamoyloxypropyl)-5-phenyl-5-ethylbarbituric acid
Manufacturers' Codes: Gö-560
Trademarks: G-Tril; Tymium (Sapos)
Molecular Formula: C20H27N3O6
Molecular Weight: 405.44
Percent Composition: C 59.25%, H 6.71%, N 10.36%, O 23.68%
Literature References: Prepn: P. Gold-Aubert, E. Gysin, Helv. Chim. Acta 44, 105 (1961); P. Gold-Aubert, US 3075983 (1963 to Sapos). Pharmacology: E. Frommel et al., Helv. Physiol. Pharmacol. Acta 19, 241 (1961). Metabolism in rats: J. Vachta, P. Gold-Aubert, Eur. J. Drug Metab. Pharmacokinet. 7, 147 (1982); in man: J. Vachta et al., ibid. 8, 297 (1983).
Properties: Syrup; could not be crystallized, dec ~196°. Sol in alcohol, dioxane. Insol in water. LD50 orally in mice: 1065 mg/kg (Frommel).
Toxicity data: LD50 orally in mice: 1065 mg/kg (Frommel)
Therap-Cat: Sedative, hypnotic.
Keywords: Sedative/Hypnotic; Barbituric Acid Derivatives.

Others monographs:
DuPHOS1-HeptanolImperatorin2-Azetidinecarboxylic Acid
Tungstic(VI) AcidDehydroergosterolLidoflazineDesosamine
NizofenoneArsenamideAmitriptylinoxideDiquat Dibromide
EtodroxizineSplendipherinMoxaverineResmethrin
©2016 DrugLead US FDA&EMEA